有投资者向复星医药提问, 有报道复星医药要出售印度公司glandp,是否属实?公司是否违规泄露重大消息?不然怎么会有这个消息?公司回答表示,投资者您好!Gland Pharma是公司全球化战略中的重要组成部分。截至目前,公司持有Gland Pharma 51.83%的股权。公司对Gland Pharma未来的长期表现充满信心,并将继续推动其在全球市场的发展和增长。感谢您对公司的关注。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.